You are using an older browser version. Please use a supported version for the best MSN experience.

AYTU BIOSCIENCE, INC.

NASDAQ: AYTU
0.9800
+0.0227
+2.37%

Sector

Healthcare

Industry

Biotechnology & Medical Research

Aytu BioScience, Inc. is a specialty pharmaceutical company. The Company markets a portfolio of prescription products addressing primary care and pediatric markets. The primary care portfolio includes Natesto, the nasal formulation of testosterone for men with hypogonadism, ZolpiMist, the oral spray prescription sleep aid, and Tuzistra XR, the 12-hour codeine-based antitussive syrup. The pediatric portfolio includes AcipHex Sprinkle, a granule formulation of rabeprazole sodium, a commonly prescribed proton pump inhibitor; Cefaclor, a second-generation cephalosporin antibiotic suspension; Karbinal ER, an extended-release carbinoxamine suspension indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various for infants and children with fluoride deficiency.

Key People

Joshua R. Disbrow

Chairman of the Board, Chief Executive Officer

David A. Green

Chief Financial Officer, Treasurer, Secretary

Jarrett T. Disbrow

Chief Operating Officer

Gary V. Cantrell

Independent Director

Carl C. Dockery

Independent Director

  • Aytu BioScience Inc

  • 373 Inverness Pkwy Ste 206

  • ENGLEWOOD, CO 80112-5898

  • US.Map

  • Phone: +1 720 4376580

  • Fax: +1 302 6365454

  • aytubio.com

Incorporated

2015

Employees

75

Insider Trades
  • Recent
  • All
  • Date

  • Name

  • Transaction

  • Shares

  • Price(s)

  • Value

    • 6/8/2020

    • CANTRELL GARY V.

    • Grant

    • 10,000

    • NA

    • NA

    • 6/8/2020

    • GREEN DAVID A

    • Grant

    • 250,000

    • NA

    • NA

    • 6/8/2020

    • DISBROW JOSHUA R

    • Grant

    • 450,000

    • NA

    • NA

    • 4/27/2020

    • ARMISTICE CAPITAL L.L.C.

    • Sold

    • 5,108,921

    • 1.82

    • 9,298,236.22

    • 4/27/2020

    • ARMISTICE CAPITAL L.L.C.

    • NA

    • 5,000,000

    • 1.25

    • 6,250,000.00

    • 4/15/2020

    • CERECOR INC

    • Sold

    • 92,777

    • 1.55

    • 144,091.96

    • 4/10/2020

    • CERECOR INC

    • NA

    • 9,805,845

    • -

    • -

    • 3/10/2020

    • ARMISTICE CAPITAL L.L.C.

    • NA

    • 15,229,161

    • 1.50

    • 22,843,741.50

    • 3/10/2020

    • ARMISTICE CAPITAL L.L.C.

    • Sold

    • 22,026,801

    • 2.05

    • 45,154,942.05

    • 1/21/2020

    • MEHTA KETAN BHUPATRAI

    • Grant

    • 10,000

    • NA

    • NA

    • 12/19/2019

    • DISBROW JOSHUA R

    • Bought

    • 55,000

    • 0.89

    • 48,994.00

    • 12/19/2019

    • ARMISTICE CAPITAL L.L.C.

    • Bought

    • 78,788

    • 0.88

    • 69,333.44

    • 10/30/2019

    • ARMISTICE CAPITAL L.L.C.

    • NA

    • 2,751,148

    • 0.88

    • 2,421,010.24

    • Date

    • Name

    • Transaction

    • Shares

    • Price(s)

    • Value

      • 6/8/2020

      • CANTRELL GARY V.

      • Grant

      • 10,000

      • NA

      • NA

      • 6/8/2020

      • GREEN DAVID A

      • Grant

      • 250,000

      • NA

      • NA

      • 6/8/2020

      • DISBROW JOSHUA R

      • Grant

      • 450,000

      • NA

      • NA

      • 4/27/2020

      • ARMISTICE CAPITAL L.L.C.

      • Sold

      • 5,108,921

      • 1.82

      • 9,298,236.22

      • 4/27/2020

      • ARMISTICE CAPITAL L.L.C.

      • NA

      • 5,000,000

      • 1.25

      • 6,250,000.00

      • 4/15/2020

      • CERECOR INC

      • Sold

      • 92,777

      • 1.55

      • 144,091.96

      • 4/10/2020

      • CERECOR INC

      • NA

      • 9,805,845

      • -

      • -

      • 3/10/2020

      • ARMISTICE CAPITAL L.L.C.

      • NA

      • 15,229,161

      • 1.50

      • 22,843,741.50

      • 3/10/2020

      • ARMISTICE CAPITAL L.L.C.

      • Sold

      • 22,026,801

      • 2.05

      • 45,154,942.05

      • 1/21/2020

      • MEHTA KETAN BHUPATRAI

      • Grant

      • 10,000

      • NA

      • NA

      • 12/19/2019

      • DISBROW JOSHUA R

      • Bought

      • 55,000

      • 0.89

      • 48,994.00

      • 12/19/2019

      • ARMISTICE CAPITAL L.L.C.

      • Bought

      • 78,788

      • 0.88

      • 69,333.44

      • 10/30/2019

      • ARMISTICE CAPITAL L.L.C.

      • NA

      • 2,751,148

      • 0.88

      • 2,421,010.24

      AdChoices
      AdChoices
      AdChoices
      image beaconimage beaconimage beacon